MAZZAGLIA GIAMPIERO

Antonazzo, I., Fornari, C., Zamparini, M., Crotti, G., Zucchi, A., Ferrara, P., et al. (2026). Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study. FRONTIERS IN PHARMACOLOGY, 17 [10.3389/fphar.2026.1708009]. Dettaglio

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Dettaglio

Boccia, A., Hyeraci, G., Girardi, A., Gini, R., Trifiro, G., Ingrasciotta, Y., et al. (2026). The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDD. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 35(5) [10.1002/pds.70379]. Dettaglio

Kirchmayer, U., Trifiro, G., Mazzaglia, G. (2026). The International Society for Pharmacoepidemiology reaches Italy: do not miss the opportunity to discuss and share your research. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 13-13 [10.19191/EP26.1.A942.008]. Dettaglio

Ferrara, P., Rozza, D., Antonazzo, I., Zamparini, M., Ferrari, E., Palladino, P., et al. (2025). Awareness and management of stage 3 chronic kidney disease among primary care practitioners in Italy: a nation-wide observational study. JN. JOURNAL OF NEPHROLOGY, 38(9), 2731-2742 [10.1007/s40620-025-02384-5]. Dettaglio